Brian Cahill - Feb 27, 2024 Form 4 Insider Report for EAGLE PHARMACEUTICALS, INC. (EGRX)

Role
CHIEF FINANCIAL OFFICER
Signature
/s/ Brian Cahill
Stock symbol
EGRX
Transactions as of
Feb 27, 2024
Transactions value $
-$10,233
Form type
4
Date filed
2/29/2024, 08:23 PM
Previous filing
Feb 6, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EGRX Common Stock Award $0 +3.8K +8.31% $0.00 49.5K Feb 27, 2024 Direct F1
transaction EGRX Common Stock Tax liability -$10.2K -1.59K -3.21% $6.44 48K Feb 27, 2024 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents common stock issued upon satisfaction of certain performance criteria contained in performance stock units ("PSUs") granted in 2021.
F2 The disposition reported on this Form 4 represents shares withheld by the Issuer to cover the tax liability upon the vesting of the PSUs and does not represent a discretionary transaction by the Reporting Person.